A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma
Ali İhsan GemiciHülya BilgenCem ErdoğanAbdullah KansuOktay OlmuşçelikHüseyin Saffet BeközRumeysa ÇakmakAli MertOmur Gokmen SevindikPublished in: Turkish journal of medical sciences (2020)
According to the results of this study, CP is an efficient conjunct to conventional therapy against COVID-19 with a favorable safety profile.